These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 12375267)
21. Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes. Takayama N; Arima S; Haraoka S; Kotho T; Futami K; Iwashita A Anticancer Res; 2003; 23(6a):4435-42. PubMed ID: 14666731 [TBL] [Abstract][Full Text] [Related]
22. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis. Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613 [TBL] [Abstract][Full Text] [Related]
23. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus. Ebrahimi M; Boldrup L; Wahlin YB; Coates PJ; Nylander K Oral Oncol; 2008 Jul; 44(7):634-8. PubMed ID: 17936670 [TBL] [Abstract][Full Text] [Related]
24. The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands. Zhang ZY; Wu YQ; Zhang WG; Tian Z; Cao J Chin J Dent Res; 2000 Nov; 3(3):36-9. PubMed ID: 11314533 [TBL] [Abstract][Full Text] [Related]
25. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Ramesh S; Nash J; McCulloch PG Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738 [TBL] [Abstract][Full Text] [Related]
26. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A Oral Oncol; 2006 Feb; 42(2):190-200. PubMed ID: 16249116 [TBL] [Abstract][Full Text] [Related]
27. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
28. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901 [TBL] [Abstract][Full Text] [Related]
29. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Sawhney M; Rohatgi N; Kaur J; Gupta SD; Deo SV; Shukla NK; Ralhan R Oral Oncol; 2007 May; 43(5):515-22. PubMed ID: 16996781 [TBL] [Abstract][Full Text] [Related]
30. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium. Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000 [TBL] [Abstract][Full Text] [Related]
31. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348 [TBL] [Abstract][Full Text] [Related]
32. Cytoplasmic expression of E-cadherin and beta-Catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas. Gao S; Eiberg H; Krogdahl A; Liu CJ; Sørensen JA J Oral Pathol Med; 2005 Feb; 34(2):116-9. PubMed ID: 15641992 [TBL] [Abstract][Full Text] [Related]
33. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375 [TBL] [Abstract][Full Text] [Related]
34. E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior. Foschini MP; Cocchi R; Morandi L; Marucci G; Pennesi MG; Righi A; Tosi AL; de Biase D; Pession A; Montebugnoli L Head Neck; 2008 Nov; 30(11):1475-82. PubMed ID: 18704970 [TBL] [Abstract][Full Text] [Related]
36. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730 [TBL] [Abstract][Full Text] [Related]
37. E-cadherin and β-catenin expression in well-differentiated and moderately-differentiated oral squamous cell carcinoma: relations with clinical variables. Rosado P; Lequerica-Fernández P; Fernández S; Allonca E; Villallaín L; de Vicente JC Br J Oral Maxillofac Surg; 2013 Mar; 51(2):149-56. PubMed ID: 22525043 [TBL] [Abstract][Full Text] [Related]
38. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression. Saegusa M; Machida D; Hashimura M; Okayasu I J Pathol; 1999 Nov; 189(3):326-37. PubMed ID: 10547593 [TBL] [Abstract][Full Text] [Related]
39. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype. Schlosshauer PW; Ellenson LH; Soslow RA Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748 [TBL] [Abstract][Full Text] [Related]
40. The hamster model of sequential oral oncogenesis. Vairaktaris E; Spyridonidou S; Papakosta V; Vylliotis A; Lazaris A; Perrea D; Yapijakis C; Patsouris E Oral Oncol; 2008 Apr; 44(4):315-24. PubMed ID: 18061531 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]